Live Breaking News & Updates on Funds Weigh In On Pacific Biosciences

Stay updated with breaking news from Funds weigh in on pacific biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $10,708.25 in Stock

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $10,708.25 in Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Pacific Biosciences , Kennedy Capital Management , Morgan Stanley , Edmond De Rothschild Holding , California Inc , Goldman Sachs Group , Axxcess Wealth Management , Interchange Capital Partners , Get Free Report , Michele Farmer , Funds Weigh In On Pacific Biosciences , Capital Management , Wealth Management , Capital Partners , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $2.00 at Barclays

Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $2.00 at Barclays
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Davidw Meline , Zurcher Kantonalbank Zurich Cantonalbank , Pacific Biosciences , Oene Mark Van , Advisor Group , California Inc , Goldman Sachs Group , China Universal Asset Management Co , Interchange Capital Partners , California Company Profile , Jpmorgan Chase Co , Free Report , California Price , Get Free Report , Director David , Funds Weigh In On Pacific Biosciences , Capital Partners , Financial Markets , Universal Asset Management , Kantonalbank Zurich Cantonalbank , California Company , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $1.93

Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $1.93
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Pacific Biosciences , Oene Mark Van , Davidw Meline , Wealth Partners , Securities Exchange Commission , California Inc , Kayne Anderson Rudnick Investment Management , Sg Americas Securities , Headlands Technologies , Jpmorgan Chase Co , Get Free Report , Exchange Commission , Director David , Funds Weigh In On Pacific Biosciences , Management Fondsmaeglerselskab , Anderson Rudnick Investment Management , Private Wealth Partners , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3%

Pacific Biosciences of California (NASDAQ:PACB) Trading Down 5.3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Zurcher Kantonalbank Zurich Cantonalbank , Sanfordc Bernstein , Pacific Biosciences , Oene Mark Van , Davidw Meline , Securities Exchange Commission , Advisor Group , California Company Profile , China Universal Asset Management Co , California Inc , Goldman Sachs Group , Interchange Capital Partners , Jpmorgan Chase Co , Get Free Report , California Stock Down , Exchange Commission , Director David , Funds Weigh In On Pacific Biosciences , Capital Partners , Financial Markets , Universal Asset Management , Kantonalbank Zurich Cantonalbank , California Company , California Daily ,

Pacific Biosciences of California (NASDAQ:PACB) PT Lowered to $8.00 at Scotiabank

Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective reduced by Scotiabank from $15.00 to $8.00 in a report published on Thursday, Benzinga reports. They currently have a sector outperform rating on the biotechnology company’s stock. Several other equities research analysts have also weighed in on PACB. Barclays reduced their target price […] ....

United States , Pacific Biosciences , Davidw Meline , Oene Mark Van , Envestnet Asset Management Inc , Goldman Sachs Group , Group Plc , Ambassador Advisors , Prudential Financial Inc , California Company Profile , California Inc , Free Report , California Price , Get Free Report , Director David , Funds Weigh In On Pacific Biosciences , Asset Management , General Group Plc , California Company , California Daily , Pacific Biosciences Of California , Nasdaq Pacb , Lower Price Target ,